AVATROMBOPAG MALEATE

AVATROMBOPAG MALEATE was reported 2368 times

AVATROMBOPAG MALEATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ORAL PURPURA 2 0.1818
1 ANTIPHOSPHOLIPID ANTIBODIES NEGATIVE 1 0.1429
2 MYELODYSPLASTIC SYNDROME WITH MULTILINEAGE DYSPLASIA 7 0.1373
3 DYSMEGAKARYOPOIESIS 1 0.0833
4 IMMATURE PLATELET FRACTION INCREASED 1 0.0833
5 SECONDARY THROMBOCYTOSIS 1 0.0526
6 HYALINE OCCLUSIVE GLOMERULAR MICROANGIOPATHY 1 0.0500
7 SCROTUM EROSION 1 0.0500
8 ADRENAL INFARCTION 1 0.0357
9 LIVER CONTUSION 1 0.0333
10 ERYTHROID DYSPLASIA 1 0.0333
11 PORTOSPLENOMESENTERIC VENOUS THROMBOSIS 2 0.0328
12 PROCEDURAL SHOCK 1 0.0278
13 PLATELET COUNT 14 0.0242
14 SENSORY PROCESSING SENSITIVITY 1 0.0227
15 MEGAKARYOCYTES DECREASED 2 0.0215
16 PERIPHERAL ARTERY STENT INSERTION 1 0.0204
17 PLATELET COUNT ABNORMAL 117 0.0193
18 MICROEMBOLISM 2 0.0175
19 SPINAL STROKE 1 0.0169
20 PLATELET COUNT INCREASED 217 0.0166
21 SIGMOID SINUS THROMBOSIS 1 0.0152
22 CEREBRAL VENOUS SINUS THROMBOSIS 10 0.0118
23 RED BLOOD CELL NUCLEATED MORPHOLOGY PRESENT 1 0.0110
24 HAEMODILUTION 1 0.0101
25 CLONAL EVOLUTION 1 0.0096
26 SUBCLAVIAN ARTERY THROMBOSIS 1 0.0092
27 FLUID INTAKE RESTRICTION 1 0.0091
28 ANTIPHOSPHOLIPID SYNDROME 13 0.0081
29 SWEATING FEVER 1 0.0072
30 PLATELET AGGREGATION ABNORMAL 1 0.0066
31 MESANGIOPROLIFERATIVE GLOMERULONEPHRITIS 1 0.0065
32 EYE PARAESTHESIA 1 0.0064
33 INTRA-ABDOMINAL PRESSURE INCREASED 1 0.0064
34 RENAL VASCULAR THROMBOSIS 1 0.0058
35 ANTI-PLATELET ANTIBODY POSITIVE 1 0.0058
36 COMPLICATIONS OF BONE MARROW TRANSPLANT 2 0.0055
37 T-LYMPHOCYTE COUNT INCREASED 1 0.0054
38 HIGH-GRADE B-CELL LYMPHOMA 1 0.0053
39 COR PULMONALE CHRONIC 1 0.0053
40 HEPATIC VASCULAR THROMBOSIS 1 0.0052
41 PATIENT DISSATISFACTION WITH TREATMENT 10 0.0052
42 ALCOHOLIC PANCREATITIS 1 0.0051
43 GINGIVAL ATROPHY 1 0.0051
44 PRODUCT PACKAGING DIFFICULT TO OPEN 13 0.0050
45 BLOOD BILIRUBIN DECREASED 3 0.0049
46 BULLOUS HAEMORRHAGIC DERMATOSIS 1 0.0048
47 PLATELET DISORDER 12 0.0048
48 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 3 0.0046
49 SCINTILLATING SCOTOMA 1 0.0045
50 RENAL VEIN THROMBOSIS 3 0.0044
51 RENAL-LIMITED THROMBOTIC MICROANGIOPATHY 1 0.0043
52 ORAL CONTUSION 1 0.0043
53 INCISION SITE HAEMATOMA 1 0.0043
54 RENAL CORTICAL NECROSIS 1 0.0043
55 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 2 0.0043
56 CEREBRAL MICROANGIOPATHY 1 0.0042
57 IMMUNE THROMBOCYTOPENIA 19 0.0041
58 ALANINE AMINOTRANSFERASE DECREASED 3 0.0041
59 PORTAL VEIN THROMBOSIS 13 0.0040
60 PLATELET COUNT DECREASED 420 0.0039
61 SUPERFICIAL VEIN PROMINENCE 1 0.0039
62 PRODUCT BLISTER PACKAGING ISSUE 4 0.0038
63 TRANSVERSE SINUS THROMBOSIS 2 0.0038
64 ARTERIOVENOUS FISTULA OPERATION 1 0.0037
65 ILIAC ARTERY OCCLUSION 1 0.0036
66 POIKILOCYTOSIS 1 0.0036
67 GASTROINTESTINAL ISCHAEMIA 1 0.0036
68 LYMPHOCYTE ADOPTIVE THERAPY 1 0.0036
69 AUTOANTIBODY POSITIVE 1 0.0036
70 DAIRY INTOLERANCE 1 0.0036
71 HEPATIC CANCER RECURRENT 1 0.0035
72 AUTOIMMUNE NEUTROPENIA 1 0.0035
73 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 2 0.0034
74 SPLENECTOMY 4 0.0034
75 BILIARY OBSTRUCTION 4 0.0031
76 POST PROCEDURAL CONTUSION 1 0.0030
77 GASTRIC MUCOSA ERYTHEMA 1 0.0030
78 MARROW HYPERPLASIA 2 0.0029
79 MEDIAL TIBIAL STRESS SYNDROME 1 0.0029
80 GALLBLADDER ENLARGEMENT 3 0.0028
81 CEREBRAL VENOUS THROMBOSIS 5 0.0028
82 PENILE ERYTHEMA 1 0.0027
83 HEPATITIS B VIRUS TEST POSITIVE 1 0.0026
84 HAEMORRHAGIC CYST 1 0.0026
85 MYOPERICARDITIS 2 0.0026
86 BLUE TOE SYNDROME 1 0.0026
87 SUPERIOR SAGITTAL SINUS THROMBOSIS 2 0.0025
88 THROMBOCYTOSIS 9 0.0025
89 MYELOFIBROSIS 7 0.0023
90 INCORRECT PRODUCT FORMULATION ADMINISTERED 2 0.0023
91 BIOPSY BONE MARROW ABNORMAL 1 0.0022
92 CIRRHOSIS ALCOHOLIC 1 0.0022
93 BIOPSY BONE MARROW 1 0.0021
94 MOTOR NEURONE DISEASE 1 0.0021
95 RED BLOOD CELL COUNT ABNORMAL 3 0.0020
96 DEPENDENCE ON OXYGEN THERAPY 1 0.0020
97 MESENTERIC VEIN THROMBOSIS 2 0.0020
98 SPLENIC VEIN THROMBOSIS 1 0.0020
99 CATARACT OPERATION COMPLICATION 1 0.0020
100 SCAPULA FRACTURE 1 0.0019
101 MILK ALLERGY 1 0.0018
102 RENAL STONE REMOVAL 1 0.0018
103 LIFE EXPECTANCY SHORTENED 1 0.0018
104 TONGUE HAEMORRHAGE 2 0.0017
105 FULL BLOOD COUNT INCREASED 2 0.0017
106 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 2 0.0017
107 MEAN PLATELET VOLUME INCREASED 1 0.0017
108 BLOOD PRESSURE MEASUREMENT 1 0.0016
109 PETECHIAE 16 0.0015
110 CHRONIC MYELOMONOCYTIC LEUKAEMIA 1 0.0015
111 ACROCHORDON 2 0.0015
112 EMBOLIC CEREBRAL INFARCTION 1 0.0015
113 MYELOPROLIFERATIVE NEOPLASM 1 0.0015
114 SUBSTANCE DEPENDENCE 1 0.0015
115 PROCEDURAL ANXIETY 1 0.0015
116 INGROWN HAIR 1 0.0014
117 POSITRON EMISSION TOMOGRAM ABNORMAL 1 0.0014
118 FLUID IMBALANCE 1 0.0014
119 ANTIBODY TEST ABNORMAL 1 0.0014
120 DRUG EFFECT LESS THAN EXPECTED 20 0.0013
121 CORNEAL DEPOSITS 1 0.0013
122 DELUSIONAL DISORDER, UNSPECIFIED TYPE 1 0.0013
123 MICROALBUMINURIA 1 0.0013
124 BASOPHIL COUNT INCREASED 1 0.0013
125 MYCOPLASMA INFECTION 1 0.0013
126 INFECTION PARASITIC 1 0.0013
127 ENTEROCOCCAL SEPSIS 1 0.0012
128 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
129 EMBOLISM 10 0.0012
130 SUPERFICIAL VEIN THROMBOSIS 1 0.0012
131 TROPONIN INCREASED 9 0.0012
132 PROCEDURAL HYPOTENSION 1 0.0012
133 CRANIOFACIAL FRACTURE 1 0.0012
134 OESOPHAGEAL OBSTRUCTION 1 0.0012
135 ARTERIAL STENOSIS 1 0.0011
136 PARAPARESIS 2 0.0011
137 HYPERPLASIA 1 0.0011
138 MUCOSAL EROSION 1 0.0011
139 GINGIVAL BLEEDING 15 0.0011
140 CHOLECYSTITIS INFECTIVE 3 0.0011
141 SCROTAL SWELLING 1 0.0011
142 ARNOLD-CHIARI MALFORMATION 1 0.0010
143 BLOOD URINE 1 0.0010
144 PCO2 DECREASED 1 0.0010
145 ONCOLOGIC COMPLICATION 1 0.0010
146 ARTERIAL THROMBOSIS 2 0.0010
147 JOINT NOISE 2 0.0010
148 HEMIANOPIA 1 0.0010
149 MUCOSAL DISORDER 1 0.0010
150 ONYCHALGIA 1 0.0010
151 VARICES OESOPHAGEAL 3 0.0010
152 PSYCHOTIC BEHAVIOUR 1 0.0010
153 EYE COLOUR CHANGE 1 0.0010
154 AMMONIA INCREASED 5 0.0010
155 STEROID WITHDRAWAL SYNDROME 1 0.0010
156 BLOOD CREATININE DECREASED 3 0.0010
157 EYE CONTUSION 2 0.0009
158 BLOOD SODIUM ABNORMAL 1 0.0009
159 LOSS OF THERAPEUTIC RESPONSE 3 0.0009
160 OESOPHAGEAL VARICES HAEMORRHAGE 2 0.0009
161 HAEMORRHAGIC DISORDER 1 0.0009
162 KIDNEY ENLARGEMENT 1 0.0009
163 RIGHT VENTRICULAR DYSFUNCTION 1 0.0009
164 FAECES PALE 2 0.0009
165 ADENOCARCINOMA 2 0.0009
166 CYTOGENETIC ABNORMALITY 1 0.0009
167 T-CELL LYMPHOMA 1 0.0009
168 AORTIC THROMBOSIS 1 0.0009
169 PRODUCT DISTRIBUTION ISSUE 8 0.0009
170 ISCHAEMIC CEREBRAL INFARCTION 1 0.0009
171 EMBOLIC STROKE 3 0.0009
172 INTRUSIVE THOUGHTS 1 0.0008
173 PULMONARY INFARCTION 2 0.0008
174 PRODUCT PACKAGING ISSUE 8 0.0008
175 SELF ESTEEM DECREASED 2 0.0008
176 INCORRECT DOSAGE ADMINISTERED 4 0.0008
177 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
178 LIP DISCOLOURATION 1 0.0008
179 FRACTURED COCCYX 1 0.0008
180 SEROMA 1 0.0008
181 PLATELET TRANSFUSION 1 0.0008
182 FULL BLOOD COUNT ABNORMAL 8 0.0008
183 EAR CONGESTION 2 0.0007
184 IMMUNOGLOBULINS DECREASED 1 0.0007
185 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
186 DISCHARGE 1 0.0007
187 TRICHORRHEXIS 2 0.0007
188 ECHOCARDIOGRAM ABNORMAL 1 0.0007
189 PERIPHERAL ARTERY THROMBOSIS 1 0.0007
190 MYELITIS TRANSVERSE 1 0.0007
191 CEREBRAL THROMBOSIS 2 0.0007
192 NOROVIRUS INFECTION 1 0.0007
193 NONINFECTIVE GINGIVITIS 1 0.0007
194 FAT TISSUE INCREASED 1 0.0007
195 AXILLARY PAIN 1 0.0007
196 SKIN STRIAE 1 0.0007
197 BONE MARROW DISORDER 2 0.0007
198 DAYDREAMING 1 0.0006
199 BLOOD BLISTER 2 0.0006
200 BACTERIAL VAGINOSIS 1 0.0006
201 GLYCOSYLATED HAEMOGLOBIN DECREASED 1 0.0006
202 ACUTE LEUKAEMIA 1 0.0006
203 LYMPHOCYTE COUNT INCREASED 2 0.0006
204 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
205 POTENTIATING DRUG INTERACTION 2 0.0006
206 HEPATORENAL SYNDROME 1 0.0006
207 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
208 SERUM FERRITIN DECREASED 1 0.0006
209 DEEP VEIN THROMBOSIS 37 0.0006
210 PURPURA 5 0.0006
211 JUGULAR VEIN THROMBOSIS 1 0.0006
212 PRODUCT SUPPLY ISSUE 4 0.0006
213 CARDIAC ABLATION 1 0.0006
214 LEUKOCYTOSIS 10 0.0006
215 LABORATORY TEST ABNORMAL 16 0.0005
216 STENOSIS 1 0.0005
217 IMPATIENCE 1 0.0005
218 AUTOIMMUNE THYROIDITIS 2 0.0005
219 PARANASAL SINUS DISCOMFORT 2 0.0005
220 HYPOPROTEINAEMIA 1 0.0005
221 HYPERCOAGULATION 1 0.0005
222 PANCREATIC CYST 1 0.0005
223 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
224 ARTERIAL DISORDER 1 0.0005
225 SKIN ATROPHY 3 0.0005
226 CONTUSION 50 0.0005
227 THERAPEUTIC PRODUCT INEFFECTIVE 2 0.0005
228 CARCINOEMBRYONIC ANTIGEN INCREASED 1 0.0005
229 PYELONEPHRITIS ACUTE 1 0.0005
230 NAIL DISCOLOURATION 2 0.0005
231 PRODUCT PRESCRIBING ISSUE 11 0.0005
232 BLOOD DISORDER 4 0.0005
233 LIPIDS INCREASED 1 0.0005
234 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 1 0.0005
235 POLYCYTHAEMIA 1 0.0005
236 INSULIN RESISTANCE 1 0.0005
237 HEPATIC CIRRHOSIS 9 0.0005
238 PHOTOPSIA 3 0.0005
239 SLEEP DEFICIT 1 0.0005
240 WHITE BLOOD CELL COUNT ABNORMAL 3 0.0005
241 ADVERSE DRUG REACTION 42 0.0005
242 PRODUCT DISPENSING ISSUE 2 0.0005
243 HAEMOGLOBIN ABNORMAL 3 0.0005
244 SPUTUM INCREASED 1 0.0005
245 INTENTIONAL DOSE OMISSION 13 0.0005
246 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 82 0.0005
247 WHEELCHAIR USER 2 0.0004
248 LARGE INTESTINAL OBSTRUCTION 1 0.0004
249 BRAIN FOG 7 0.0004
250 INTENTIONAL PRODUCT MISUSE 39 0.0004
251 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
252 HEPATIC ENCEPHALOPATHY 4 0.0004
253 BLOOD TEST ABNORMAL 6 0.0004
254 SEASONAL ALLERGY 6 0.0004
255 LEUKAEMIA 4 0.0004
256 MYOPIA 1 0.0004
257 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
258 MYELODYSPLASTIC SYNDROME 6 0.0004
259 PREMATURE RUPTURE OF MEMBRANES 1 0.0004
260 FAECES SOFT 3 0.0004
261 PRODUCT PACKAGING CONFUSION 1 0.0004
262 BREATH ODOUR 1 0.0004
263 MOUTH HAEMORRHAGE 3 0.0004
264 PHARYNGEAL SWELLING 4 0.0004
265 HEADACHE 252 0.0004
266 PRODUCT DOSE OMISSION ISSUE 118 0.0004
267 HEPATIC ENZYME ABNORMAL 2 0.0004
268 BLOOD COUNT ABNORMAL 6 0.0004
269 ABNORMAL UTERINE BLEEDING 1 0.0004
270 EAR DISCOMFORT 4 0.0004
271 FOOD ALLERGY 3 0.0004
272 EPISTAXIS 29 0.0004
273 PRODUCT USE COMPLAINT 6 0.0004
274 PRODUCT USE ISSUE 71 0.0004
275 SCIATICA 6 0.0004
276 EYE HAEMORRHAGE 5 0.0004
277 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
278 SKIN LACERATION 4 0.0004
279 RHINALGIA 1 0.0004
280 DEAFNESS UNILATERAL 2 0.0004
281 RED BLOOD CELL COUNT INCREASED 1 0.0004
282 SERUM SICKNESS 1 0.0004
283 NECK MASS 1 0.0004
284 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
285 HAEMATOLOGICAL MALIGNANCY 1 0.0004
286 RED BLOOD CELL COUNT DECREASED 10 0.0003
287 LIP PAIN 1 0.0003
288 THROMBOSIS 28 0.0003
289 EXERCISE TOLERANCE DECREASED 2 0.0003
290 PULMONARY EMBOLISM 33 0.0003
291 FIBULA FRACTURE 1 0.0003
292 DYSPNOEA AT REST 1 0.0003
293 RALES 2 0.0003
294 BILIARY COLIC 1 0.0003
295 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
296 HEAD DISCOMFORT 6 0.0003
297 ENERGY INCREASED 2 0.0003
298 BLOOD IRON DECREASED 4 0.0003
299 FACIAL PAIN 3 0.0003
300 HEAVY MENSTRUAL BLEEDING 3 0.0003
301 CEREBROVASCULAR DISORDER 1 0.0003
302 EMERGENCY CARE 1 0.0003
303 PENILE PAIN 1 0.0003
304 DIABETIC FOOT 1 0.0003
305 INTRACARDIAC THROMBUS 1 0.0003
306 EMOTIONAL DISORDER 10 0.0003
307 PORTAL HYPERTENSION 1 0.0003
308 INJECTION SITE HYPERSENSITIVITY 1 0.0003
309 CUSHINGOID 1 0.0003
310 PRESCRIBED OVERDOSE 6 0.0003
311 RHINORRHOEA 20 0.0003
312 BLOOD POTASSIUM INCREASED 5 0.0003
313 HAEMORRHOIDS 6 0.0003
314 HAEMORRHAGE 32 0.0003
315 FLATULENCE 17 0.0003
316 PLANTAR FASCIITIS 1 0.0003
317 FULL BLOOD COUNT DECREASED 6 0.0003
318 HEPATIC CYST 1 0.0003
319 ILLNESS 30 0.0003
320 APLASIA PURE RED CELL 1 0.0003
321 RESPIRATION ABNORMAL 2 0.0003
322 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
323 TENDERNESS 3 0.0003
324 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
325 HYPERTRANSAMINASAEMIA 2 0.0003
326 AORTIC STENOSIS 1 0.0003
327 TRANSFUSION 3 0.0003
328 CAROTID ARTERY STENOSIS 1 0.0003
329 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
330 HEPATOCELLULAR INJURY 4 0.0003
331 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
332 FIBRIN D DIMER INCREASED 1 0.0003
333 CEREBRAL HAEMORRHAGE 10 0.0003
334 BACK INJURY 3 0.0003
335 PULMONARY THROMBOSIS 3 0.0003
336 LIVER TRANSPLANT 1 0.0003
337 SPONDYLITIS 1 0.0003
338 BONE PAIN 16 0.0003
339 FOOD INTOLERANCE 1 0.0003
340 AMYLASE INCREASED 1 0.0003
341 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
342 TENDON INJURY 1 0.0003
343 THERAPEUTIC PRODUCT EFFECT DECREASED 12 0.0003
344 HYDRONEPHROSIS 2 0.0003
345 GENERAL SYMPTOM 2 0.0003
346 LOSS OF CONTROL OF LEGS 1 0.0003
347 PARANASAL SINUS HYPERSECRETION 1 0.0003
348 INSURANCE ISSUE 4 0.0003
349 GASTRIC INFECTION 1 0.0003
350 GINGIVAL DISORDER 1 0.0003
351 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
352 REHABILITATION THERAPY 1 0.0003
353 PANIC DISORDER 1 0.0003
354 EAR PAIN 5 0.0003
355 FAECES HARD 1 0.0003
356 HAEMORRHAGIC STROKE 2 0.0003
357 PROCEDURAL HAEMORRHAGE 1 0.0003
358 PNEUMONIA FUNGAL 1 0.0003
359 BACTERAEMIA 3 0.0003
360 DRUG INEFFECTIVE 333 0.0003
361 CHOLECYSTITIS 3 0.0003
362 AZOTAEMIA 1 0.0003
363 INTRACRANIAL ANEURYSM 1 0.0002
364 FUNGAL SKIN INFECTION 1 0.0002
365 FRUSTRATION TOLERANCE DECREASED 2 0.0002
366 PAIN IN JAW 7 0.0002
367 PERIPHERAL SWELLING 38 0.0002
368 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
369 PERIPHERAL ISCHAEMIA 1 0.0002
370 FATIGUE 189 0.0002
371 SPINAL STENOSIS 1 0.0002
372 PHARYNGITIS 3 0.0002
373 MENSTRUAL DISORDER 2 0.0002
374 FUNGAL INFECTION 8 0.0002
375 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
376 MUSCLE FATIGUE 1 0.0002
377 POOR PERIPHERAL CIRCULATION 1 0.0002
378 HEPATIC PAIN 1 0.0002
379 PULMONARY TUBERCULOSIS 1 0.0002
380 VITAMIN D DECREASED 2 0.0002
381 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
382 MUSCULOSKELETAL DISCOMFORT 4 0.0002
383 HORDEOLUM 1 0.0002
384 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
385 BONE CANCER 1 0.0002
386 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
387 RASH MACULAR 8 0.0002
388 IMMUNOSUPPRESSION 2 0.0002
389 ABDOMINAL DISCOMFORT 38 0.0002
390 GINGIVAL SWELLING 1 0.0002
391 ADVERSE REACTION 3 0.0002
392 QUALITY OF LIFE DECREASED 3 0.0002
393 HAEMOLYTIC ANAEMIA 2 0.0002
394 SNEEZING 5 0.0002
395 MENINGITIS ASEPTIC 1 0.0002
396 ANAL INCONTINENCE 2 0.0002
397 MIGRAINE 21 0.0002
398 PRODUCT AVAILABILITY ISSUE 5 0.0002
399 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
400 EAR DISORDER 1 0.0002
401 CHRONIC MYELOID LEUKAEMIA 1 0.0002
402 GASTRITIS EROSIVE 1 0.0002
403 CHOLELITHIASIS 7 0.0002
404 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
405 SARCOIDOSIS 1 0.0002
406 KIDNEY TRANSPLANT REJECTION 1 0.0002
407 BLOOD PRESSURE FLUCTUATION 5 0.0002
408 RASH VESICULAR 1 0.0002
409 GUILLAIN-BARRE SYNDROME 1 0.0002
410 THROMBOTIC MICROANGIOPATHY 2 0.0002
411 HORMONE LEVEL ABNORMAL 1 0.0002
412 ASCITES 6 0.0002
413 VITREOUS FLOATERS 2 0.0002
414 ARTHRITIS 16 0.0002
415 NASAL POLYPS 1 0.0002
416 PANCREATIC DISORDER 1 0.0002
417 WHITE BLOOD CELL COUNT DECREASED 22 0.0002
418 LIVER DISORDER 9 0.0002
419 SKIN HAEMORRHAGE 3 0.0002
420 HYPERVOLAEMIA 1 0.0002
421 SINUS DISORDER 4 0.0002
422 HAEMORRHAGE INTRACRANIAL 3 0.0002
423 FLUID INTAKE REDUCED 1 0.0002
424 DRUG TOLERANCE 1 0.0002
425 DRY THROAT 2 0.0002
426 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 1 0.0002
427 ENDOCARDITIS 1 0.0002
428 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
429 CEREBRAL ISCHAEMIA 1 0.0002
430 PERIPHERAL VASCULAR DISORDER 1 0.0002
431 HAEMATOMA 5 0.0002
432 SWELLING 18 0.0002
433 MALABSORPTION 1 0.0002
434 APLASTIC ANAEMIA 1 0.0002
435 ARTHRALGIA 79 0.0002
436 ANORECTAL DISCOMFORT 1 0.0002
437 FOOD POISONING 1 0.0002
438 COMPRESSION FRACTURE 1 0.0002
439 LIVER FUNCTION TEST INCREASED 4 0.0002
440 PRODUCT SIZE ISSUE 1 0.0002
441 BEHAVIOUR DISORDER 1 0.0002
442 PHARYNGITIS STREPTOCOCCAL 2 0.0002
443 BACK DISORDER 3 0.0002
444 NONSPECIFIC REACTION 1 0.0002
445 ASTHENOPIA 1 0.0002
446 CHOKING SENSATION 1 0.0002
447 GAIT INABILITY 6 0.0002
448 HAEMOPTYSIS 5 0.0002
449 ACUTE PULMONARY OEDEMA 1 0.0002
450 EYE INFECTION 2 0.0002
451 PERIORBITAL SWELLING 1 0.0002
452 CHOLECYSTITIS ACUTE 1 0.0002
453 PERONEAL NERVE PALSY 1 0.0002
454 IMPAIRED DRIVING ABILITY 2 0.0002
455 CHOLECYSTECTOMY 2 0.0002
456 INTERNAL HAEMORRHAGE 2 0.0002
457 HYPERSOMNIA 5 0.0002
458 TINNITUS 8 0.0002
459 CORONARY ARTERY BYPASS 1 0.0002
460 GASTRIC HAEMORRHAGE 2 0.0002
461 HERPES VIRUS INFECTION 1 0.0002
462 MOUTH SWELLING 1 0.0002
463 BLOOD URIC ACID INCREASED 1 0.0002
464 LIVER FUNCTION TEST ABNORMAL 5 0.0002
465 PRODUCT LABEL CONFUSION 1 0.0002
466 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
467 DECREASED INTEREST 1 0.0002
468 ACUTE MYOCARDIAL INFARCTION 5 0.0002
469 CATARACT OPERATION 1 0.0002
470 THIRST 3 0.0002
471 ASTHENIA 63 0.0002
472 POLYNEUROPATHY 2 0.0002
473 PAIN IN EXTREMITY 49 0.0002
474 HEPATITIS CHOLESTATIC 1 0.0002
475 LACRIMATION INCREASED 5 0.0002
476 PELVIC PAIN 3 0.0002
477 MENTAL IMPAIRMENT 4 0.0002
478 NEURALGIA 4 0.0002
479 TREATMENT NONCOMPLIANCE 9 0.0002
480 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
481 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
482 MENISCUS INJURY 1 0.0002
483 PIGMENTATION DISORDER 1 0.0002
484 CHOLANGITIS 1 0.0002
485 OLIGURIA 1 0.0002
486 BACTERIAL INFECTION 3 0.0002
487 INFUSION SITE EXTRAVASATION 1 0.0002
488 COVID-19 28 0.0002
489 NASAL DRYNESS 1 0.0002
490 CEREBROVASCULAR ACCIDENT 27 0.0002
491 BLOOD SODIUM DECREASED 3 0.0002
492 INFUSION SITE SWELLING 1 0.0002
493 BLEPHAROSPASM 1 0.0002
494 HEAD INJURY 5 0.0002
495 NAUSEA 123 0.0002
496 HERNIA 3 0.0002
497 ORAL HERPES 3 0.0002
498 ABDOMINAL DISTENSION 16 0.0002
499 KIDNEY INFECTION 3 0.0002
500 POLYP 1 0.0002
501 BEDRIDDEN 2 0.0002
502 SARS-COV-2 TEST POSITIVE 2 0.0002
503 APPETITE DISORDER 1 0.0002
504 CARDIAC FAILURE ACUTE 1 0.0001
505 PRODUCT ADMINISTRATION ERROR 3 0.0001
506 BLOOD BILIRUBIN INCREASED 4 0.0001
507 FEEDING DISORDER 3 0.0001
508 HEPATIC ENZYME INCREASED 10 0.0001
509 INFARCTION 1 0.0001
510 HAEMOGLOBIN DECREASED 15 0.0001
511 ECCHYMOSIS 1 0.0001
512 HAIR GROWTH ABNORMAL 1 0.0001
513 LARGE INTESTINE POLYP 1 0.0001
514 PULMONARY HYPERTENSION 3 0.0001
515 AUTOIMMUNE HEPATITIS 1 0.0001
516 EXTRASYSTOLES 1 0.0001
517 MOUTH ULCERATION 3 0.0001
518 CONSTIPATION 31 0.0001
519 SKIN REACTION 2 0.0001
520 DUODENAL ULCER 1 0.0001
521 HEART RATE INCREASED 14 0.0001
522 DIZZINESS 70 0.0001
523 METASTASIS 1 0.0001
524 PARALYSIS 2 0.0001
525 GRAFT VERSUS HOST DISEASE 1 0.0001
526 PARAESTHESIA ORAL 2 0.0001
527 FAECES DISCOLOURED 3 0.0001
528 SWELLING FACE 9 0.0001
529 DIARRHOEA 89 0.0001
530 BACK PAIN 32 0.0001
531 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
532 FLUID RETENTION 7 0.0001
533 BLOOD PRESSURE INCREASED 21 0.0001
534 ABDOMINAL PAIN UPPER 28 0.0001
535 BLINDNESS TRANSIENT 1 0.0001
536 ARTHROPOD BITE 1 0.0001
537 HEPATOTOXICITY 3 0.0001
538 PULMONARY MASS 2 0.0001
539 SUNBURN 1 0.0001
540 ORAL PAIN 3 0.0001
541 RESPIRATORY DISORDER 4 0.0001
542 HEART RATE IRREGULAR 3 0.0001
543 PAROSMIA 1 0.0001
544 OFF LABEL USE 116 0.0001
545 VISION BLURRED 18 0.0001
546 BOWEL MOVEMENT IRREGULARITY 1 0.0001
547 PROCEDURAL COMPLICATION 1 0.0001
548 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
549 LYMPHOMA 2 0.0001
550 LIMB DISCOMFORT 4 0.0001
551 URINARY TRACT INFECTION 22 0.0001
552 DELUSION 2 0.0001
553 EJECTION FRACTION DECREASED 2 0.0001
554 HYPOALBUMINAEMIA 1 0.0001
555 RASH 56 0.0001
556 NERVOUS SYSTEM DISORDER 4 0.0001
557 GASTROINTESTINAL INFLAMMATION 1 0.0001
558 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
559 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
560 CYANOSIS 2 0.0001
561 HAEMATOCHEZIA 7 0.0001
562 FURUNCLE 1 0.0001
563 PRODUCT PRESCRIBING ERROR 3 0.0001
564 RENAL CYST 1 0.0001
565 THROMBOCYTOPENIA 14 0.0001
566 NIGHT SWEATS 4 0.0001
567 HYPERSENSITIVITY 23 0.0001
568 MYALGIA 21 0.0001
569 DRY MOUTH 10 0.0001
570 CEREBRAL INFARCTION 3 0.0001
571 PRODUCT DOSE OMISSION 8 0.0001
572 LIVER INJURY 3 0.0001
573 POLYURIA 1 0.0001
574 ABNORMAL FAECES 1 0.0001
575 ESCHERICHIA INFECTION 1 0.0001
576 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1 0.0001
577 ACUTE CORONARY SYNDROME 1 0.0001
578 HEMIPLEGIA 1 0.0001
579 MUSCLE SPASMS 22 0.0001
580 NASAL CONGESTION 7 0.0001
581 EYE PRURITUS 4 0.0001
582 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
583 SENSATION OF FOREIGN BODY 1 0.0001
584 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
585 HAEMATEMESIS 3 0.0001
586 HEMIPARESIS 2 0.0001
587 HEPATITIS 3 0.0001
588 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
589 JOINT SWELLING 14 0.0001
590 NO ADVERSE EVENT 21 0.0001
591 BLOOD MAGNESIUM DECREASED 1 0.0001
592 MUSCLE STRAIN 1 0.0001
593 CARDIAC MURMUR 1 0.0001
594 DIPLOPIA 3 0.0001
595 PYELONEPHRITIS 1 0.0001
596 VAGINAL HAEMORRHAGE 5 0.0001
597 SOMNOLENCE 23 0.0001
598 SLEEP DISORDER 8 0.0001
599 DRUG ERUPTION 2 0.0001
600 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
601 RESPIRATORY RATE INCREASED 1 0.0001
602 ISCHAEMIC STROKE 2 0.0001
603 GALLBLADDER DISORDER 2 0.0001
604 GASTROOESOPHAGEAL REFLUX DISEASE 9 0.0001
605 ABDOMINAL PAIN 26 0.0001
606 GOUT 2 0.0001
607 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
608 THROAT IRRITATION 5 0.0001
609 THERAPY NON-RESPONDER 5 0.0001
610 GASTROENTERITIS VIRAL 2 0.0001
611 TOOTHACHE 2 0.0001
612 DEATH 95 0.0001
613 RESTLESS LEGS SYNDROME 2 0.0001
614 HIDRADENITIS 1 0.0001
615 SKIN DISCOLOURATION 5 0.0001
616 CONDITION AGGRAVATED 33 0.0001
617 FEELING ABNORMAL 26 0.0001
618 OVARIAN CANCER 1 0.0001
619 NERVE COMPRESSION 1 0.0001
620 PROCEDURAL PAIN 3 0.0001
621 PERSONALITY CHANGE 1 0.0001
622 NECK PAIN 6 0.0001
623 WOUND 3 0.0001
624 RENAL DISORDER 5 0.0001
625 DIARRHOEA HAEMORRHAGIC 1 0.0001
626 ALOPECIA 21 0.0001
627 FLANK PAIN 1 0.0001
628 PHOTOPHOBIA 2 0.0001
629 ABORTION INDUCED 1 0.0001
630 BLOOD URINE PRESENT 2 0.0001
631 PROTEINURIA 2 0.0001
632 PRODUCTIVE COUGH 5 0.0001
633 HERPES ZOSTER 6 0.0001
634 CHOLESTASIS 2 0.0001
635 LOWER LIMB FRACTURE 2 0.0001
636 AFFECT LABILITY 1 0.0001
637 GLAUCOMA 2 0.0001
638 ATELECTASIS 1 0.0001
639 DIZZINESS POSTURAL 1 0.0001
640 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
641 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
642 PLASMA CELL MYELOMA 4 0.0001
643 COELIAC DISEASE 1 0.0001
644 HEPATOMEGALY 1 0.0001
645 PRURITUS 39 0.0001
646 INSOMNIA 27 0.0001
647 HOSPICE CARE 1 0.0001
648 BLADDER DISORDER 1 0.0001
649 INABILITY TO AFFORD MEDICATION 1 0.0001
650 INJECTION SITE BRUISING 8 0.0001
651 DRY EYE 5 0.0001
652 PLEURAL EFFUSION 6 0.0001
653 TASTE DISORDER 2 0.0001
654 OEDEMA PERIPHERAL 12 0.0001
655 EYELID PTOSIS 1 0.0001
656 SUBARACHNOID HAEMORRHAGE 1 0.0001
657 BODY TEMPERATURE INCREASED 2 0.0001
658 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
659 NASOPHARYNGITIS 18 0.0001
660 INITIAL INSOMNIA 1 0.0001
661 RIB FRACTURE 2 0.0001
662 OROPHARYNGEAL PAIN 9 0.0001
663 INFECTION 14 0.0001
664 SWOLLEN TONGUE 3 0.0001
665 NERVOUSNESS 5 0.0001
666 ROAD TRAFFIC ACCIDENT 4 0.0001
667 JOINT DISLOCATION 1 0.0001
668 CYSTITIS 3 0.0001
669 BREAST PAIN 1 0.0001
670 VOMITING 44 0.0001
671 IMPAIRED WORK ABILITY 2 0.0001
672 BREAST CANCER METASTATIC 1 0.0001
673 POOR QUALITY SLEEP 2 0.0001
674 COUGH 26 0.0001
675 DECREASED ACTIVITY 1 0.0001
676 UNEVALUABLE EVENT 7 0.0001
677 PRURITUS GENERALISED 2 0.0001
678 PYREXIA 32 0.0001
679 MENSTRUATION DELAYED 1 0.0001
680 BIPOLAR DISORDER 1 0.0001
681 CHEST PAIN 17 0.0001
682 MYOCARDIAL INFARCTION 16 0.0001
683 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
684 DYSPEPSIA 9 0.0001
685 STAPHYLOCOCCAL INFECTION 3 0.0001
686 DECREASED APPETITE 21 0.0001
687 DENTAL CARIES 1 0.0001
688 FOOT DEFORMITY 1 0.0001
689 VIRAL INFECTION 3 0.0001
690 PULMONARY OEDEMA 4 0.0001
691 OCULAR DISCOMFORT 1 0.0001
692 BLOOD CALCIUM DECREASED 1 0.0001
693 PRODUCT USE IN UNAPPROVED INDICATION 22 0.0001
694 CHROMATURIA 2 0.0001
695 MITRAL VALVE INCOMPETENCE 1 0.0001
696 MYOCARDIAL ISCHAEMIA 1 0.0001
697 DERMATITIS CONTACT 1 0.0001
698 MICTURITION URGENCY 1 0.0001
699 LETHARGY 5 0.0001
700 PNEUMONIA 28 0.0001
701 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
702 HEART RATE DECREASED 3 0.0001
703 SPLENOMEGALY 1 0.0001
704 COVID-19 PNEUMONIA 1 0.0001
705 CATARACT 5 0.0001
706 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
707 HEPATIC CANCER 2 0.0001
708 LOCALISED INFECTION 2 0.0001
709 DRUG EFFECT INCOMPLETE 3 0.0001
710 THERAPEUTIC RESPONSE DECREASED 5 0.0001
711 NOCTURIA 1 0.0001
712 PANIC ATTACK 3 0.0001
713 UNDERDOSE 6 0.0001
714 ACCIDENTAL OVERDOSE 3 0.0001
715 CYTOPENIA 1 0.0001
716 ENCEPHALOPATHY 2 0.0001
717 EYE SWELLING 3 0.0001
718 CYST 1 0.0001
719 PAIN 49 0.0001
720 HOT FLUSH 6 0.0001
721 ACNE 6 0.0001
722 INTRAOCULAR PRESSURE INCREASED 1 0.0001
723 ROTATOR CUFF SYNDROME 1 0.0001
724 DRUG RESISTANCE 2 0.0001
725 INFUSION SITE PAIN 1 0.0001
726 INFLAMMATION 4 0.0001
727 UNRESPONSIVE TO STIMULI 2 0.0001
728 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
729 GASTRITIS 2 0.0001
730 ADVERSE EVENT 7 0.0001
731 IMMUNE SYSTEM DISORDER 1 0.0001
732 DISORIENTATION 3 0.0001
733 DEPRESSED MOOD 4 0.0001
734 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
735 DRY SKIN 10 0.0001
736 FEAR 2 0.0001
737 FREQUENT BOWEL MOVEMENTS 2 0.0001
738 SINUS CONGESTION 1 0.0001
739 THROAT TIGHTNESS 2 0.0001
740 DYSPHAGIA 7 0.0001
741 AKATHISIA 1 0.0001
742 GAIT DISTURBANCE 14 0.0001
743 OSTEOPOROSIS 3 0.0001
744 SKIN LESION 2 0.0001
745 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
746 VISUAL IMPAIRMENT 9 0.0001
747 DRUG INTOLERANCE 7 0.0001
748 TREMOR 12 0.0001
749 DIVERTICULITIS 2 0.0001
750 FALL 24 0.0001
751 ORAL DISCOMFORT 1 0.0001
752 HUNGER 1 0.0001
753 APHONIA 1 0.0001
754 WEIGHT DECREASED 20 0.0001
755 DEMENTIA 2 0.0001
756 WEIGHT INCREASED 16 0.0001
757 CARPAL TUNNEL SYNDROME 1 0.0001
758 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
759 HYPERTENSION 15 0.0001
760 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
761 LOSS OF CONSCIOUSNESS 9 0.0001
762 SUBDURAL HAEMATOMA 1 0.0001
763 ANGINA PECTORIS 2 0.0001
764 CARDIOGENIC SHOCK 1 0.0001
765 ACCIDENTAL UNDERDOSE 1 0.0001
766 SEIZURE 8 0.0001
767 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
768 INJECTION SITE HAEMATOMA 1 0.0001
769 GASTROENTERITIS 1 0.0001
770 DYSSTASIA 2 0.0001
771 MUSCULOSKELETAL STIFFNESS 6 0.0001
772 CHEST DISCOMFORT 7 0.0001
773 PALPITATIONS 8 0.0001
774 SINUSITIS 7 0.0001
775 TACHYCARDIA 6 0.0001
776 COLON CANCER 1 0.0001
777 GASTROINTESTINAL DISORDER 6 0.0001
778 HYPOAESTHESIA 10 0.0001
779 APHASIA 2 0.0001
780 STOMATITIS 4 0.0001
781 OSTEOPENIA 1 0.0001
782 VERTIGO 4 0.0001
783 MEMORY IMPAIRMENT 9 0.0001
784 NEPHROLITHIASIS 3 0.0001
785 HOSPITALISATION 10 0.0001
786 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
787 MUSCULOSKELETAL CHEST PAIN 1 0.0001
788 TENDONITIS 1 0.0001
789 BLOOD GLUCOSE INCREASED 12 0.0001
790 OCULAR HYPERAEMIA 3 0.0001
791 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
792 NEUROPATHY PERIPHERAL 6 0.0001
793 PNEUMOTHORAX 1 0.0001
794 DRUG INTERACTION 10 0.0001
795 RESPIRATORY TRACT CONGESTION 1 0.0001
796 ANAEMIA 12 0.0001
797 RASH ERYTHEMATOUS 3 0.0001
798 MOOD SWINGS 2 0.0001
799 SENSORY DISTURBANCE 1 0.0001
800 MUSCULAR WEAKNESS 7 0.0001
801 MALAISE 27 0.0001
802 METASTASES TO BONE 1 0.0001
803 PHOTOSENSITIVITY REACTION 1 0.0001
804 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
805 CYTOMEGALOVIRUS INFECTION 1 0.0001
806 COAGULOPATHY 1 0.0001
807 DEHYDRATION 8 0.0001
808 AGGRESSION 3 0.0001
809 NEOPLASM MALIGNANT 4 0.0001
810 BLOOD UREA INCREASED 1 0.0001
811 CHILLS 7 0.0001
812 CELLULITIS 3 0.0001
813 CANDIDA INFECTION 1 0.0001
814 ANGER 2 0.0001
815 CIRCULATORY COLLAPSE 1 0.0001
816 THERAPY CESSATION 3 0.0001
817 ERYTHEMA 12 0.0001
818 NIGHTMARE 2 0.0001
819 ORTHOSTATIC HYPOTENSION 1 0.0001
820 BURNING SENSATION 4 0.0001
821 METASTASES TO LIVER 1 0.0001
822 COLD SWEAT 1 0.0001
823 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
824 RASH PRURITIC 3 0.0001
825 OSTEOMYELITIS 1 0.0001
826 CRYING 2 0.0001
827 RESPIRATORY FAILURE 4 0.0001
828 END STAGE RENAL DISEASE 1 0.0001
829 RESTLESSNESS 2 0.0001
830 BLOOD GLUCOSE ABNORMAL 1 0.0001
831 ARTHROPATHY 3 0.0001
832 CONJUNCTIVITIS 1 0.0001
833 INFLUENZA 6 0.0001
834 HEPATIC STEATOSIS 1 0.0001
835 MIDDLE INSOMNIA 1 0.0001
836 BLISTER 3 0.0001
837 OXYGEN SATURATION DECREASED 3 0.0001
838 HYPONATRAEMIA 3 0.0001
839 EYE PAIN 3 0.0001
840 DYSARTHRIA 2 0.0001
841 DYSPNOEA EXERTIONAL 2 0.0001
842 RENAL FAILURE 7 0.0001
843 ANXIETY 15 0.0001
844 GASTRIC ULCER 1 0.0001
845 DIABETES MELLITUS 4 0.0001
846 INCREASED APPETITE 1 0.0001
847 EYE IRRITATION 3 0.0001
848 POST PROCEDURAL COMPLICATION 1 0.0001
849 ACUTE RESPIRATORY FAILURE 1 0.0001
850 ERUCTATION 1 0.0001
851 DYSTONIA 1 0.0001
852 ATRIAL FIBRILLATION 5 0.0001
853 DYSPNOEA 29 0.0001
854 SKIN FISSURES 1 0.0001
855 HAEMATOCRIT DECREASED 1 0.0001
856 BLOOD PRESSURE ABNORMAL 1 0.0001
857 PRESCRIBED UNDERDOSE 1 0.0001
858 SPINAL FRACTURE 1 0.0000
859 IRRITABILITY 3 0.0000
860 BONE MARROW FAILURE 1 0.0000
861 BLINDNESS 2 0.0000
862 NEUTROPHIL COUNT DECREASED 2 0.0000
863 FEELING HOT 3 0.0000
864 PERITONITIS 1 0.0000
865 URTICARIA 8 0.0000
866 KNEE ARTHROPLASTY 1 0.0000
867 SKIN EXFOLIATION 4 0.0000
868 EATING DISORDER 1 0.0000
869 RETCHING 1 0.0000
870 IRRITABLE BOWEL SYNDROME 1 0.0000
871 HYPERHIDROSIS 6 0.0000
872 RECTAL HAEMORRHAGE 2 0.0000
873 SKIN CANCER 1 0.0000
874 BALANCE DISORDER 4 0.0000
875 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
876 MENTAL DISORDER 2 0.0000
877 MELAENA 1 0.0000
878 COLITIS ULCERATIVE 2 0.0000
879 PARAESTHESIA 7 0.0000
880 RHEUMATOID ARTHRITIS 5 0.0000
881 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
882 SHOCK 1 0.0000
883 CARDIAC DISORDER 4 0.0000
884 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
885 THERAPY INTERRUPTED 3 0.0000
886 MOBILITY DECREASED 3 0.0000
887 HYPOGLYCAEMIA 2 0.0000
888 FIBROMYALGIA 1 0.0000
889 PRESYNCOPE 1 0.0000
890 BRONCHITIS 3 0.0000
891 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
892 AGEUSIA 1 0.0000
893 PNEUMONIA ASPIRATION 1 0.0000
894 LEUKOPENIA 2 0.0000
895 SYNCOPE 4 0.0000
896 DEPRESSION 9 0.0000
897 INCORRECT DOSE ADMINISTERED 9 0.0000
898 EXPOSURE VIA SKIN CONTACT 1 0.0000
899 RESPIRATORY TRACT INFECTION 1 0.0000
900 ECZEMA 2 0.0000
901 SPEECH DISORDER 2 0.0000
902 PANCREATITIS 2 0.0000
903 EAR INFECTION 1 0.0000
904 MENSTRUATION IRREGULAR 1 0.0000
905 JAUNDICE 1 0.0000
906 DISTURBANCE IN ATTENTION 2 0.0000
907 OEDEMA 2 0.0000
908 LIMB INJURY 1 0.0000
909 NEUTROPENIA 5 0.0000
910 PALLOR 1 0.0000
911 MOOD ALTERED 1 0.0000
912 INFLUENZA LIKE ILLNESS 3 0.0000
913 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
914 MENTAL STATUS CHANGES 1 0.0000
915 FEELING COLD 1 0.0000
916 PANCYTOPENIA 2 0.0000
917 RENAL IMPAIRMENT 3 0.0000
918 DISEASE PROGRESSION 4 0.0000
919 BLOOD POTASSIUM DECREASED 1 0.0000
920 HEPATIC FAILURE 1 0.0000
921 ILL-DEFINED DISORDER 2 0.0000
922 DISCOMFORT 2 0.0000
923 ACUTE KIDNEY INJURY 5 0.0000
924 DRUG-INDUCED LIVER INJURY 1 0.0000
925 MOVEMENT DISORDER 1 0.0000
926 HIP FRACTURE 1 0.0000
927 LACTIC ACIDOSIS 1 0.0000
928 AMNESIA 2 0.0000
929 INFUSION RELATED REACTION 2 0.0000
930 LIP SWELLING 1 0.0000
931 SKIN DISORDER 1 0.0000
932 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
933 HAEMATURIA 1 0.0000
934 GASTRIC DISORDER 1 0.0000
935 NEOPLASM PROGRESSION 1 0.0000
936 LYMPHADENOPATHY 1 0.0000
937 HYPERGLYCAEMIA 1 0.0000
938 DYSGEUSIA 2 0.0000
939 HEPATIC FUNCTION ABNORMAL 1 0.0000
940 HALLUCINATION 2 0.0000
941 INTESTINAL OBSTRUCTION 1 0.0000
942 CHRONIC KIDNEY DISEASE 2 0.0000
943 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
944 ABORTION SPONTANEOUS 1 0.0000
945 CARDIAC FAILURE 2 0.0000
946 CARDIAC FAILURE CONGESTIVE 2 0.0000
947 CONFUSIONAL STATE 4 0.0000
948 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
949 DYSKINESIA 1 0.0000
950 LUNG NEOPLASM MALIGNANT 1 0.0000
951 POLLAKIURIA 1 0.0000
952 CARDIO-RESPIRATORY ARREST 1 0.0000
953 OSTEOARTHRITIS 1 0.0000
954 SEPTIC SHOCK 1 0.0000
955 PRODUCT STORAGE ERROR 2 0.0000
956 SKIN IRRITATION 1 0.0000
957 BLOOD CHOLESTEROL INCREASED 1 0.0000
958 COGNITIVE DISORDER 1 0.0000
959 ARRHYTHMIA 1 0.0000
960 DISEASE RECURRENCE 1 0.0000
961 RENAL CANCER 1 0.0000
962 MULTIPLE SCLEROSIS 1 0.0000
963 BLOOD GLUCOSE DECREASED 1 0.0000
964 LUNG DISORDER 1 0.0000
965 FLUSHING 2 0.0000
966 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
967 MUSCULOSKELETAL PAIN 1 0.0000
968 DERMATITIS ATOPIC 1 0.0000
969 ANAPHYLACTIC REACTION 1 0.0000
970 MEDICATION ERROR 1 0.0000
971 SEPSIS 2 0.0000
972 SURGERY 1 0.0000
973 BLADDER CANCER 1 0.0000
974 INJECTION SITE ERYTHEMA 2 0.0000
975 EXPOSURE DURING PREGNANCY 1 0.0000
976 BLOOD CREATININE INCREASED 1 0.0000
977 HYPOTENSION 3 0.0000
978 INJECTION SITE PRURITUS 1 0.0000
979 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
980 INJECTION SITE REACTION 1 0.0000
981 SKIN BURNING SENSATION 1 0.0000
982 PROSTATE CANCER 1 0.0000
983 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
984 SUICIDAL IDEATION 1 0.0000
985 INJECTION SITE PAIN 3 0.0000
986 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
987 OVERDOSE 2 0.0000
988 ASTHMA 1 0.0000
989 EMOTIONAL DISTRESS 1 0.0000